trending Market Intelligence /marketintelligence/en/news-insights/trending/jOf7C6EYAXvLmDXh4UNpXg2 content esgSubNav
In This List

Thermo Fisher closes debt offerings

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Thermo Fisher closes debt offerings

Thermo Fisher Scientific Inc. raised about €4.33 billion and $890.68 million in net proceeds from two separate senior notes placements in Europe and the U.S.

In the U.S. offering, that closed Oct. 8, the Waltham, Mass.-based company issued $900 million aggregate principal amount of its 2.6% senior notes due 2029.

Meanwhile, under the the European offering, that closed Sept. 30, the company issued €800 million aggregate principal amount of its 0.125% senior notes due 2025; €800 million aggregate principal amount of its 0.500% senior notes due 2028; €900 million aggregate principal amount of its 0.875% senior notes due 2031; €900 million aggregate principal amount of its 1.5% senior notes due 2039; and €1 billion aggregate principal amount of its 1.875% senior notes due 2049.

The life sciences giant intends to use the proceeds to fund the redemption of the principal amount of several outstanding senior notes, the company said in an Oct. 8 press release.